Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer - Concepedia

Concepedia

Publication | Open Access

Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer

DOI Full Paper Access

41

Citations

83

References

1997

Year

Sebastian Fetscher, Wolfram Brugger, R. Engelhardt, Lothar Kanz, J. Hasse, H Frommhold, Michael Wenger, W. Lange, Roland Mertelsmann

Annals of Oncology

References

	Year	Citations

Page 1